Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

09/26/2023 - 04:34 PM

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Attachment

PHXM_Master RFA 2023_06 (1)

ERPY

:ERPY

ERPY Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

ERPY Latest News

Oct 9, 2023

PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains

Oct 4, 2023

PHAXIAM Receives Compliance Notice from Nasdaq

Oct 3, 2023

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration

Sep 21, 2023

PHAXIAM Provides Business and Financial Update For the First Half of 2023

Sep 19, 2023

PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target

ERPY Stock Data